No Data
No Data
Bohui Innovation: 2024 Annual Report Summary
Bohui Innovation: 2024 Annual Report
Express News | The Concept of Blood Product rises against the trend, Beijing Bohui Innovation Biotechnology Group increases by over 10%.
Express News | Beijing Bohui Innovation Biotechnology Group: received government subsidy funds of 2.9 million yuan.
Express News | Beijing Bohui Innovation Biotechnology Group: The holding subsidiary jointly obtained the clinical trial approval notice for the trivalent influenza virus subunit vaccine.
Bohui Innovation: 2024 Annual Performance Forecast